Effects of therapeutic hypothermia on the glial proteome and phenotype

Current Protein and Peptide Science

Volumn 14, Issue 1, 2013, Pages 51-60

  Kim, Jong Heon ^a   Seo, Minchul ^a   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Glia; Hypothermia; Ischemia; Neuroinflammation; Proteome

Indexed keywords

AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CD200 ANTIGEN; CD47 ANTIGEN; FRACTALKINE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 2; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEOME; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ASTROCYTOSIS; AUTOPHAGY; CELL ACTIVATION; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GLIA CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE RESPONSE; INDUCED HYPOTHERMIA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; REPERFUSION INJURY; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; BRAIN ISCHEMIA; HUMANS; HYPOTHERMIA, INDUCED; MALE; NEUROGLIA; PHENOTYPE; PROTEIN INTERACTION MAPS; PROTEOME; REPERFUSION INJURY;

ANIMALIA;

EID: 84876728859     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203711314010008     Document Type: Article

References (116)

1. Polderman, K. H. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet, 2008, 371(9628), 1955-1969.
2. Bayir, H.; Adelson, P. D.; Wisniewski, S. R.; Shore, P.; Lai, Y.; Brown, D.; Janesko-Feldman, K. L.; Kagan, V. E.; Kochanek, P. M. Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit. Care Med., 2009, 37(2), 689-695.
3. Liang, C.; Wang, J. Z.; Li, X. [Local mild hypothermia therapy for neurogenic pulmonary edema]. Nan Fang Yi Ke Da Xue Xue Bao, 2008, 28(9), 1696-1699.
4. Kim, J. H.; Cho, Y. E.; Seo, M.; Baek, M. C.; Suk, K. Glial proteome changes in response to moderate hypothermia. Proteomics, 2012, 12(15-16), 2571-2583.
5. Klassman, L. Therapeutic hypothermia in acute stroke. J. Neurosci. Nurs., 2011, 43(2), 94-103.
6. Zhao, Q. J.; Zhang, X. G.; Wang, L. X. Mild hypothermia therapy reduces blood glucose and lactate and improves neurologic outcomes in patients with severe traumatic brain injury. J. Crit. Care, 2011, 26(3), 311-315.
7. Kollmar, R.; Staykov, D.; Dorfler, A.; Schellinger, P. D.; Schwab, S.; Bardutzky, J. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke, 2010, 41(8), 1684-1689.
8. Shintani, Y.; Terao, Y.; Ohta, H. Molecular mechanisms underlying hypothermia-induced neuroprotection. Stroke Res. Treat, 2010, 2011, 809874.
9. Gonzalez-Ibarra, F. P.; Varon, J.; Lopez-Meza, E. G. Therapeutic hypothermia: critical review of the molecular mechanisms of action. Front. Neurol., 2011, 2, 4.
10. Goubard, V.; Fino, E.; Venance, L. Contribution of astrocytic glutamate and GABA uptake to corticostriatal information processing. J. Physiol., 2011, 589(Pt 9), 2301-2319.
11. Prebil, M.; Jensen, J.; Zorec, R.; Kreft, M. Astrocytes and energy metabolism. Arch. Physiol. Biochem., 2011, 117(2), 64-69.
12. Sofroniew, M. V.; Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol, 2010, 119(1), 7-35.
13. Kettenmann, H.; Hanisch, U. K.; Noda, M.; Verkhratsky, A. Physiology of microglia. Physiol. Rev., 2011, 91(2), 461-553.
14. Kumar, K.; Wu, X.; Evans, A. T. GFAP-immunoreactivity following hypothermic forebrain ischemia. Metab. Brain Dis., 1997, 12(1), 21-27.
15. Plesnila, N.; Muller, E.; Guretzki, S.; Ringel, F.; Staub, F.; Baethmann, A. Effect of hypothermia on the volume of rat glial cells. J. Physiol., 2000, 523 Pt 1, 155-162.
16. Wilhelmsson, U.; Bushong, E. A.; Price, D. L.; Smarr, B. L.; Phung, V.; Terada, M.; Ellisman, M. H.; Pekny, M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(46), 17513-17518.
17. Eddleston, M.; Mucke, L. Molecular profile of reactive astrocytes-- implications for their role in neurologic disease. Neuroscience, 1993, 54(1), 15-36.
18. Cho, W.; Messing, A. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Exp. Cell Res., 2009, 315(7), 1260-1272.
19. Nash, B.; Ioannidou, K.; Barnett, S. C. Astrocyte phenotypes and their relationship to myelination. J. Anat., 2011, 219(1), 44-52.
20. Sofroniew, M. V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci., 2009, 32(12), 638-647.
21. Zamanian, J. L.; Xu, L.; Foo, L. C.; Nouri, N.; Zhou, L.; Giffard, R. G.; Barres, B. A. Genomic analysis of reactive astrogliosis. J. Neurosci., 2012, 32(18), 6391-6410.
22. Lee, S.; Kim, J. H.; Kim, J. H.; Seo, J. W.; Han, H. S.; Lee, W. H.; Mori, K.; Nakao, K.; Barasch, J.; Suk, K. Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration. J. Biol. Chem., 2011, 286(51), 43855-43870.
23. Lee, S.; Lee, J.; Kim, S.; Park, J. Y.; Lee, W. H.; Mori, K.; Kim, S. H.; Kim, I. K.; Suk, K. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol., 2007, 179(5), 3231-3241.
24. Tremblay, M. E.; Stevens, B.; Sierra, A.; Wake, H.; Bessis, A.; Nimmerjahn, A. The role of microglia in the healthy brain. J. Neurosci., 2011, 31(45), 16064-16069.
25. Lyons, A.; Downer, E. J.; Crotty, S.; Nolan, Y. M.; Mills, K. H.; Lynch, M. A. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J. Neurosci., 2007, 27(31), 8309-8313.
26. Lauro, C.; Catalano, M.; Trettel, F.; Mainiero, F.; Ciotti, M. T.; Eusebi, F.; Limatola, C. The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit. J. Immunol., 2006, 177(11), 7599-7606.
27. Pabon, M. M.; Bachstetter, A. D.; Hudson, C. E.; Gemma, C.; Bickford, P. C. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation, 2011, 8, 9.
28. Imai, Y.; Ibata, I.; Ito, D.; Ohsawa, K.; Kohsaka, S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun., 1996, 224(3), 855-862.
29. Imai, Y.; Kohsaka, S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia, 2002, 40(2), 164-174.
30. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J. V.; Zuo, Y.; Jung, S.; Littman, D. R.; Dustin, M. L.; Gan, W. B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci., 2005, 8(6), 752-758.
31. Walter, L.; Franklin, A.; Witting, A.; Wade, C.; Xie, Y.; Kunos, G.; Mackie, K.; Stella, N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci., 2003, 23(4), 1398-1405.
32. Rappert, A.; Biber, K.; Nolte, C.; Lipp, M.; Schubel, A.; Lu, B.; Gerard, N. P.; Gerard, C.; Boddeke, H. W.; Kettenmann, H. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J. Immunol., 2002, 168(7), 3221-3226.
33. Schwab, A. Function and spatial distribution of ion channels and transporters in cell migration. Am. J. Physiol. Renal Physiol., 2001, 280(5), F739-747.
34. Schwab, A. Ion channels and transporters on the move. News Physiol. Sci., 2001, 16, 29-33.
35. Ifuku, M.; Farber, K.; Okuno, Y.; Yamakawa, Y.; Miyamoto, T.; Nolte, C.; Merrino, V. F.; Kita, S.; Iwamoto, T.; Komuro, I.; Wang, B.; Cheung, G.; Ishikawa, E.; Ooboshi, H.; Bader, M.; Wada, K.; Kettenmann, H.; Noda, M. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J. Neurosci., 2007, 27(48), 13065-13073.
36. Aloisi, F. Immune function of microglia. Glia, 2001, 36(2), 165-179.
37. Lee, T. I.; Yang, C. S.; Fang, K. M.; Tzeng, S. F. Role of ciliary neurotrophic factor in microglial phagocytosis. Neurochem. Res., 2009, 34(1), 109-117.
38. Chang, Y. P.; Fang, K. M.; Lee, T. I.; Tzeng, S. F. Regulation of microglial activities by glial cell line derived neurotrophic factor. J. Cell. Biochem., 2006, 97(3), 501-511.
39. Mitrasinovic, O. M.; Murphy, G. M., Jr. Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Abeta. Neurobiol. Aging, 2003, 24(6), 807-815.
40. Shie, F. S.; Montine, K. S.; Breyer, R. M.; Montine, T. J. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. Glia, 2005, 52(1), 70-77.
41. Fang, K. M.; Yang, C. S.; Sun, S. H.; Tzeng, S. F. Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action. J. Neurochem., 2009, 111(5), 1225-1237.
42. Manna, P. P.; Frazier, W. A. The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J. Immunol., 2003, 170(7), 3544-3553.
43. Xie, C.; Zhang, N.; Zhou, H.; Li, J.; Li, Q.; Zarubin, T.; Lin, S. C.; Han, J. Distinct roles of basal steady-state and induced H-ferritin in tumor necrosis factor-induced death in L929 cells. Mol. Cell. Biol., 2005, 25(15), 6673-6681.
44. Van Herreweghe, F.; Mao, J.; Chaplen, F. W.; Grooten, J.; Gevaert, K.; Vandekerckhove, J.; Vancompernolle, K. Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE. Proc. Natl. Acad. Sci. U. S. A., 2002, 99(2), 949-954.
45. Viviani, B.; Corsini, E.; Binaglia, M.; Lucchi, L.; Galli, C. L.; Marinovich, M. The anti-inflammatory activity of estrogen in glial cells is regulated by the PKC-anchoring protein RACK-1. J. Neurochem., 2002, 83(5), 1180-1187.
46. Polavarapu, R.; Gongora, M. C.; Yi, H.; Ranganthan, S.; Lawrence, D. A.; Strickland, D.; Yepes, M. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood, 2007, 109(8), 3270-3278.
47. Tardif, K. D.; Waris, G.; Siddiqui, A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol., 2005, 13(4), 159-163.
48. He, F.; Sun, Y. E. Glial cells more than support cells? Int. J. Biochem. Cell Biol., 2007, 39(4), 661-665.
49. Choi, J. S.; Park, J.; Suk, K.; Moon, C.; Park, Y. K.; Han, H. S. Mild Hypothermia Attenuates Intercellular Adhesion Molecule-1 Induction via Activation of Extracellular Signal-Regulated Kinase- 1/2 in a Focal Cerebral Ischemia Model. Stroke Res. Treat., 2011, 2011, 846716.
50. O'Shea, J. J.; Gadina, M.; Schreiber, R. D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell, 2002, 109 Suppl, S121-131.
51. Yang, N.; Luo, M.; Li, R.; Huang, Y.; Zhang, R.; Wu, Q.; Wang, F.; Li, Y.; Yu, X. Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol. Dial. Transplant., 2008, 23(1), 91-100.
52. Wang, G. J.; Deng, H. Y.; Maier, C. M.; Sun, G. H.; Yenari, M. A. Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke. Neuroscience, 2002, 114(4), 1081-1090.
53. Kim, O. S.; Park, E. J.; Joe, E. H.; Jou, I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J. Biol. Chem., 2002, 277(43), 40594-40601.
54. Kawamura, N.; Schmeichel, A. M.; Wang, Y.; Schmelzer, J. D.; Low, P. A. Multiple effects of hypothermia on inflammatory response following ischemia-reperfusion injury in experimental ischemic neuropathy. Exp. Neurol., 2006, 202(2), 487-496.
55. Halonen, S. K.; Woods, T.; McInnerney, K.; Weiss, L. M. Microarray analysis of IFN-gamma response genes in astrocytes. J. Neuroimmunol., 2006, 175(1-2), 19-30.
56. Lee, C. G.; Demarquoy, J.; Jackson, M. J.; O'Brien, W. E. Molecular cloning and characterization of a murine LPS-inducible cDNA. J Immunol, 1994, 152(12), 5758-5767.
57. Seo, M.; Kim J. H.; Cho Y. E.; Beak M. C.; Suk, K. Hypothermic regulation of astrocyte proteome profile in experimental stroke. Electrophoresis, 2012, 33(24), 3835-3848.
58. Niciu, M. J.; Kelmendi, B.; Sanacora, G. Overview of glutamatergic neurotransmission in the nervous system. Pharmacol. Biochem. Behav., 2012, 100(4), 656-664.
59. Chatterton, J. E.; Awobuluyi, M.; Premkumar, L. S.; Takahashi, H.; Talantova, M.; Shin, Y.; Cui, J.; Tu, S.; Sevarino, K. A.; Nakanishi, N.; Tong, G.; Lipton, S. A.; Zhang, D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature, 2002, 415(6873), 793-798.
60. Henson, M. A.; Roberts, A. C.; Salimi, K.; Vadlamudi, S.; Hamer, R. M.; Gilmore, J. H.; Jarskog, L. F.; Philpot, B. D. Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb. Cortex, 2008, 18(11), 2560-2573.
61. Takadera, T.; Ohyashiki, T. Temperature-dependent N-methyl-Daspartate receptor-mediated cytotoxicity in cultured rat cortical neurons. Neurosci. Lett., 2007, 423(1), 24-28.
62. Krebs, C.; Fernandes, H. B.; Sheldon, C.; Raymond, L. A.; Baimbridge, K. G. Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro. J. Neurosci., 2003, 23(8), 3364-3372.
63. Takadera, T.; Shimada, Y.; Mohri, T. Extracellular pH modulates N-methyl-D-aspartate receptor-mediated neurotoxicity and calcium accumulation in rat cortical cultures. Brain Res., 1992, 572(1-2), 126-131.
64. Uchihori, Y.; Puro, D. G. Glutamate as a neuron-to-glial signal for mitogenesis: role of glial N-methyl-D-aspartate receptors. Brain Res., 1993, 613(2), 212-220.
65. Cameron, H. A.; Hazel, T. G.; McKay, R. D. Regulation of neurogenesis by growth factors and neurotransmitters. J. Neurobiol., 1998, 36(2), 287-306.
66. Takarada, T.; Hara, T.; Konishi, S.; Nakazato, R.; Yoneda, Y. Selective downregulation of N-methyl-D-aspartate receptor (NMDAR) rather than non-NMDAR subunits in ipsilateral cerebral hemispheres in rats with middle cerebral artery occlusion. Nihon Shinkei Seishin Yakurigaku Zasshi, 2011, 31(4), 187-194.
67. Noh, K. M.; Hwang, J. Y.; Follenzi, A.; Athanasiadou, R.; Miyawaki, T.; Greally, J. M.; Bennett, M. V.; Zukin, R. S. Repressor element-1 silencing transcription factor (REST)- dependent epigenetic remodeling is critical to ischemia-induced neuronal death. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(16), E962-971.
68. Palmer, C. L.; Cotton, L.; Henley, J. M. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid receptors. Pharmacol. Rev., 2005, 57(2), 253-277.
69. Shi, S. H.; Hayashi, Y.; Petralia, R. S.; Zaman, S. H.; Wenthold, R. J.; Svoboda, K.; Malinow, R. Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science, 1999, 284(5421), 1811-1816.
70. Honore, T.; Lauridsen, J.; Krogsgaard-Larsen, P. The binding of [3H]AMPA, a structural analogue of glutamic acid, to rat brain membranes. J. Neurochem., 1982, 38(1), 173-178.
71. Dos-Anjos, S.; Martinez-Villayandre, B.; Montori, S.; Regueiro- Purrinos, M. M.; Gonzalo-Orden, J. M.; Fernandez-Lopez, A. Global ischemia-induced modifications in the expression of AMPA receptors and inflammation in rat brain. Brain Res., 2009, 1287, 20-27.
72. Friedman, L. K.; Ginsberg, M. D.; Belayev, L.; Busto, R.; Alonso, O. F.; Lin, B.; Globus, M. Y. Intraischemic but not postischemic hypothermia prevents non-selective hippocampal downregulation of AMPA and NMDA receptor gene expression after global ischemia. Brain Res. Mol. Brain Res., 2001, 86(1-2), 34-47.
73. Gorter, J. A.; Petrozzino, J. J.; Aronica, E. M.; Rosenbaum, D. M.; Opitz, T.; Bennett, M. V.; Connor, J. A.; Zukin, R. S. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J. Neurosci., 1997, 17(16), 6179-6188.
74. Yenari, M. A.; Han, H. S. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat. Rev. Neurosci., 2012, 13(4), 267-278.
75. Colbourne, F.; Grooms, S. Y.; Zukin, R. S.; Buchan, A. M.; Bennett, M. V. Hypothermia rescues hippocampal CA1 neurons and attenuates down-regulation of the AMPA receptor GluR2 subunit after forebrain ischemia. Proc. Natl. Acad. Sci. U. S. A., 2003, 100(5), 2906-2910.
76. Mattson, M. P.; Duan, W.; Pedersen, W. A.; Culmsee, C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis, 2001, 6(1-2), 69-81.
77. Kowaltowski, A. J.; Castilho, R. F.; Vercesi, A. E. Mitochondrial permeability transition and oxidative stress. FEBS Lett., 2001, 495(1-2), 12-15.
78. Ford-Hutchinson, A. W. Leukotrienes as mediators of human disease. Adv. Prostaglandin. Thromboxane. Leukot. Res., 1985, 15, 353-355.
79. Islam, O.; Loo, T. X.; Heese, K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr. Neurovasc. Res., 2009, 6(1), 42-53.
80. Ploughman, M.; Windle, V.; MacLellan, C. L.; White, N.; Dore, J. J.; Corbett, D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke, 2009, 40(4), 1490-1495.
81. Huang, E. J.; Reichardt, L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem., 2003, 72, 609-642.
82. Sung, J. H.; Kim, M. O.; Koh, P. O. Proteomic identification of proteins differentially expressed by nicotinamide in focal cerebral ischemic injury. Neuroscience, 2011, 174, 171-177.
83. Hyakkoku, K.; Hamanaka, J.; Tsuruma, K.; Shimazawa, M.; Hara, H. Proteomic approach with LCMS-IT-TOF identified an increase of Rab33B after transient focal cerebral ischemia in mice. Exp. Transl. Stroke Med., 2010, 2(1), 20.
84. Datta, A.; Jingru, Q.; Khor, T. H.; Teo, M. T.; Heese, K.; Sze, S. K. Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia/reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers. J. Proteome Res., 2011, 10(11), 5199-5213.
85. D'Cruz, B. J.; Fertig, K. C.; Filiano, A. J.; Hicks, S. D.; DeFranco, D. B.; Callaway, C. W. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J. Cereb. Blood Flow Metab., 2002, 22(7), 843-851.
86. Vosler, P. S.; Logue, E. S.; Repine, M. J.; Callaway, C. W. Delayed hypothermia preferentially increases expression of brain-derived neurotrophic factor exon III in rat hippocampus after asphyxial cardiac arrest. Brain Res. Mol. Brain Res., 2005, 135(1-2), 21-29.
87. Boris-Moller, F.; Wieloch, T. Changes in the extracellular levels of glutamate and aspartate during ischemia and hypoglycemia. Effects of hypothermia. Exp. Brain Res., 1998, 121(3), 277-284.
88. Berger, C.; Schabitz, W. R.; Wolf, M.; Mueller, H.; Sommer, C.; Schwab, S. Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp. Neurol., 2004, 185(2), 305-312.
89. Hattori, T.; Takei, N.; Mizuno, Y.; Kato, K.; Kohsaka, S. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci. Res., 1995, 21(3), 191-198.
90. Millward, T. A.; Zolnierowicz, S.; Hemmings, B. A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci., 1999, 24(5), 186-191.
91. Zolnierowicz, S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem. Pharmacol., 2000, 60(8), 1225-1235.
92. Janssens, V.; Goris, J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J., 2001, 353(Pt 3), 417-439.
93. Koh, P. O. Focal Cerebral Ischemia Reduces Protein Phosphatase 2A Subunit B Expression in Brain Tissue and HT22 Cells. Lab. Anim. Res., 2011, 27(1), 73-76.
94. Fergani, A.; Dupuis, L.; Jokic, N.; Larmet, Y.; de Tapia, M.; Rene, F.; Loeffler, J. P.; Gonzalez de Aguilar, J. L. Reticulons as markers of neurological diseases: focus on amyotrophic lateral sclerosis. Neurodegener. Dis., 2005, 2(3-4), 185-194.
95. Yan, R.; Shi, Q.; Hu, X.; Zhou, X. Reticulon proteins: emerging players in neurodegenerative diseases. Cell. Mol. Life Sci., 2006, 63(7-8), 877-889.
96. He, W.; Lu, Y.; Qahwash, I.; Hu, X. Y.; Chang, A.; Yan, R. Reticulon family members modulate BACE1 activity and amyloidbeta peptide generation. Nat. Med., 2004, 10(9), 959-965.
97. Tagami, S.; Eguchi, Y.; Kinoshita, M.; Takeda, M.; Tsujimoto, Y. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene, 2000, 19(50), 5736-5746.
98. Steiner, P.; Kulangara, K.; Sarria, J. C.; Glauser, L.; Regazzi, R.; Hirling, H. Reticulon 1-C/neuroendocrine-specific protein-C interacts with SNARE proteins. J. Neurochem., 2004, 89(3), 569-580.
99. Kim, H. R.; Chae, H. J.; Thomas, M.; Miyazaki, T.; Monosov, A.; Monosov, E.; Krajewska, M.; Krajewski, S.; Reed, J. C. Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis. FASEB J., 2007, 21(1), 188-196.
100. Saveanu, C.; Fromont-Racine, M.; Harington, A.; Ricard, F.; Namane, A.; Jacquier, A. Identification of 12 new yeast mitochondrial ribosomal proteins including 6 that have no prokaryotic homologues. J. Biol. Chem., 2001, 276(19), 15861-15867.
101. Cavdar Koc, E.; Burkhart, W.; Blackburn, K.; Moseley, A.; Spremulli, L. L. The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present. J. Biol. Chem., 2001, 276(22), 19363-19374.
102. Denslow, N. D.; Anders, J. C.; O'Brien, T. W. Bovine mitochondrial ribosomes possess a high affinity binding site for guanine nucleotides. J. Biol. Chem., 1991, 266(15), 9586-9590.
103. Fu, H.; Subramanian, R. R.; Masters, S. C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol., 2000, 40, 617-647.
104. Ho, M. C.; Lo, A. C.; Kurihara, H.; Yu, A. C.; Chung, S. S.; Chung, S. K. Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J., 2001, 15(3), 618-626.
105. Ubl, A.; Berg, D.; Holzmann, C.; Kruger, R.; Berger, K.; Arzberger, T.; Bornemann, A.; Riess, O. 14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. Brain Res. Mol. Brain Res., 2002, 108(1-2), 33-39.
106. Chen, X. Q.; Chen, J. G.; Zhang, Y.; Hsiao, W. W.; Yu, A. C. 14-3- 3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes. Glia, 2003, 42(4), 315-324.
107. Kurz, A.; May, C.; Schmidt, O.; Muller, T.; Stephan, C.; Meyer, H. E.; Gispert, S.; Auburger, G.; Marcus, K. A53T-alpha-synucleinoverexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP. J. Neural Transm., 2012, 119(3), 297-312.
108. Broughton, B. R.; Reutens, D. C.; Sobey, C. G. Apoptotic mechanisms after cerebral ischemia. Stroke, 2009, 40(5), e331-339.
109. Huang, H. F.; Guo, F.; Cao, Y. Z.; Shi, W.; Xia, Q. Neuroprotection by Manganese Superoxide Dismutase (MnSOD) Mimics: Antioxidant Effect and Oxidative Stress Regulation in Acute Experimental Stroke. CNS Neurosci. Ther., 2012, 18(10), 811-818.
110. Peters, O.; Back, T.; Lindauer, U.; Busch, C.; Megow, D.; Dreier, J.; Dirnagl, U. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab., 1998, 18(2), 196-205.
111. Ferrero-Gutierrez, A.; Perez-Gomez, A.; Novelli, A.; Fernandez- Sanchez, M. T. Inhibition of protein phosphatases impairs the ability of astrocytes to detoxify hydrogen peroxide. Free Radic. Biol. Med., 2008, 44(10), 1806-1816.
112. Wilson, J. X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol., 1997, 75(10-11), 1149-1163.
113. Rao, A. K.; Dietrich, A. K.; Ziegler, Y. S.; Nardulli, A. M. 17beta- Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia. J. Steroid Biochem. Mol. Biol., 2011, 127(3-5), 382-389.
114. Qiao, H.; Dong, L.; Zhang, X.; Zhu, C.; Zhang, X.; Wang, L.; Liu, Z.; Chen, L.; Xing, Y.; Wang, C.; Li, Y. Protective Effect of Luteolin in Experimental Ischemic Stroke: Upregulated SOD1, CAT, Bcl-2 and Claudin-5, Down-Regulated MDA and Bax Expression. Neurochem. Res., 2012, 37(9), 2014-2024.
115. Boulos, S.; Meloni, B. P.; Arthur, P. G.; Bojarski, C.; Knuckey, N. W. Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury. J. Neurosci. Res., 2007, 85(14), 3089-3097.
116. Fujii, J.; Ikeda, Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep., 2002, 7(3), 123-130.